{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:26:21Z","timestamp":1775949981510,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jpba.2013.11.032","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T17:46:23Z","timestamp":1386438383000},"page":"180-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Analysis of rocuronium in human plasma by liquid chromatography\u2013tandem mass spectrometry with application in clinical pharmacokinetics"],"prefix":"10.1016","volume":"90","author":[{"given":"Nat\u00e1lia Valadares","family":"de Moraes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Rocha","family":"Lauretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Campos de Oliveira","family":"Filgueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3389-6993","authenticated-orcid":false,"given":"Bruno Carvalho Portes","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia","family":"Lanchote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.11.032_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0952-8180(98)00056-7","article-title":"A comparative study of the dose\u2013response and time course of action of rocuronium and vecuronium in anesthetized adult patients","volume":"10","author":"Xue","year":"1998","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0010","first-page":"1140","article-title":"Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients","volume":"55","author":"Shingu","year":"2006","journal-title":"Masui"},{"key":"10.1016\/j.jpba.2013.11.032_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(24)35082-7","article-title":"Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipathic type II organic cations","volume":"291","author":"Van Montfoort","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2013.11.032_bib0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/bja\/85.5.717","article-title":"Urinary, biliary and faecal excretion of rocuronium in humans","volume":"85","author":"Proost","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2125.1997.00653.x","article-title":"The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis","volume":"44","author":"Van Miert","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2013.11.032_bib0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0265021505001584","article-title":"Pharmacodynamics of rocuronium 0.3mgkg(\u22121) in adult patients with and without renal failure","volume":"22","author":"Robertson","year":"2005","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.jpba.2013.11.032_bib0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1460-9592.2006.02181.x","article-title":"Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK\/PD analysis","volume":"17","author":"Woloszczuk-Gebicka","year":"2007","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2044.2006.04862.x","article-title":"Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium","volume":"62","author":"Maybauer","year":"2007","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jpba.2013.11.032_bib0045","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1213\/00000539-199906000-00026","article-title":"The costs of intense neuromuscular block for anesthesia during endolaryngeal procedures due to waiting time","volume":"88","author":"Puura","year":"1999","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jpba.2013.11.032_bib0050","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/00000542-200306000-00006","article-title":"Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade","volume":"98","author":"Eikermann","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpba.2013.11.032_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.200512-1862OC","article-title":"The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade","volume":"175","author":"Eikermann","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jpba.2013.11.032_bib0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/bja\/80.3.386","article-title":"Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsivant therapy with sodium valproate and primidone","volume":"80","author":"Driessen","year":"1998","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12630-013-9909-7","article-title":"Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia","volume":"60","author":"Murata","year":"2013","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0310057X1204000219","article-title":"Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs","volume":"40","author":"Ledowski","year":"2012","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.jpba.2013.11.032_bib0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/bja\/aeq157","article-title":"Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge","volume":"105","author":"Butterly","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0080","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/clinchem\/46.9.1413","article-title":"Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography\u2013tandem mass spectrometry","volume":"46","author":"Gutteck-Amsler","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2013.11.032_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0021-9673(00)01164-X","article-title":"Quantitative determination of rocuronium in human plasma by liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"910","author":"Farenc","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.11.032_bib0090","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/rcm.812","article-title":"Liquid chromatography\/mass spectrometric bioanalysis of a modified gamma-cyclodextrin (Org 25969) and Rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the plasma pharmacokinetics of Org 25969","volume":"16","author":"Epemolu","year":"2002","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2013.11.032_bib0095","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"Food and Drug Administration Center for Drug Evaluation and Research","year":"2001"},{"key":"10.1016\/j.jpba.2013.11.032_bib0100","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jpba.2013.11.032_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-4347(93)80077-H","article-title":"Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates","volume":"621","author":"Kleef","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2013.11.032_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-4347(97)00367-8","article-title":"Quantification of the neuromuscular blocking agent rocuronium and its putative metabolite 17-desacetylrocuronium in heparinized plasma by capillary gas chromatography using a nitrogen sensitive detector","volume":"702","author":"Probst","year":"1997","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2013.11.032_bib0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0952-8180(94)90075-2","article-title":"Clinical pharmacology of rocuronium (Org 9426): study of the time of course of action, dose requirement, reversibility, and pharmacokinetics","volume":"6","author":"Van Den Broek","year":"1994","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.jpba.2013.11.032_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03017322","article-title":"Rocuronium pharmacokinetic\u2013pharmacodynamic relationship under stable propofol or isoflurane anesthesia","volume":"49","author":"Dragne","year":"2002","journal-title":"Can. J. Anesth."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513005736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513005736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:15:57Z","timestamp":1746069357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513005736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":24,"alternative-id":["S0731708513005736"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.11.032","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of rocuronium in human plasma by liquid chromatography\u2013tandem mass spectrometry with application in clinical pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}